MSD Strengthens Its R&D Leadership in Spain: Up 8% From the Previous Year, Reaching 209 Cl... 25/05/2026 Healthcare Access to innovation Innovative drugs The biomedical Company MSD, a leader in research, has reached a new milestone in its commitment to science and... Partners - MSD
Webinar NeuroTech Devices: Regulatory, Preclinical, and Clinical Insights Del 03/06/2026 17:00 to 03/06/2026 18:00 Healthcare Access to innovation Innovative drugs
ORYZON reports financial results and corporate update for quarter ended March 31st, 2026 19/05/2026 Healthcare Drug discovery Innovative drugs Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79%... Partners - Oryzon Genomics
VIVEbiotech and Zelluna Partnership to Advance Off-the Shelf TCR-NK Cell Therapy with GMP ... 19/05/2026 Healthcare Innovative drugs Advanced therapies Partnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo... Partners - VIVEbiotech
VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell 18/05/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve... Partners - VIVEbiotech
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemi... 13/05/2026 Healthcare Drug discovery Innovative drugs In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a... Partners - Oryzon Genomics
Making Pharma Spain 2027 Barcelona Spain Del 17/02/2027 to 18/02/2027 Healthcare Innovative drugs Industrial biotechnology
Upcoming Webinar: The Art and Science of Cyclic Peptide Drug Design: From Experimental Dis... Del 27/05/2026 to 27/05/2026 Healthcare Drug discovery Innovative drugs International Digitalization
BCN HEALTH publishes a study evaluating the incidence, management, and associated costs of... 05/05/2026 Healthcare Innovative drugs Personalized medicine Partners - BCN Health
The IIBB-CSIC and Chemotargets promote the development of new therapies against cancer t... 29/04/2026 Healthcare Drug discovery Innovative drugs The agreement combines the preclinical models developed by the Institute of Biomedical Research of Barcelona (IIBB-CSIC)... Partners - Parc Científic de Barcelona
